About PeptideGuide
About PeptideGuide
PeptideGuide is an independent research reference dedicated to making peptide science accessible, accurate, and transparent. We compile, organise, and present peer-reviewed research on bioactive peptides — from well-established compounds like BPC-157 and semaglutide to emerging candidates in clinical trials.
Our Mission
Peptide research is growing rapidly, but reliable, well-organised information remains fragmented across journals, preprints, and forums. PeptideGuide exists to bridge that gap — providing structured research profiles, mechanism breakdowns, and head-to-head comparisons grounded in published evidence.
We do not sell peptides, recommend treatments, or provide medical advice. Our role is strictly educational: we present what the science says and where the evidence stands.
What We Cover
- 58 peptide research profiles — each covering mechanism of action, pharmacokinetics, clinical evidence, and safety data
- 62 head-to-head comparisons — structured side-by-side analyses of related compounds
- 17 research goal categories — from muscle growth and neuroprotection to metabolic health and immune support
- 15 peptide classes — GH secretagogues, GLP-1 agonists, melanocortin peptides, and more
- 26 mechanism pathways — detailed breakdowns of how peptides interact with biological systems
- Research glossary — plain-language definitions of key terms in peptide science
Editorial Independence
PeptideGuide is not affiliated with any peptide manufacturer, supplier, or clinic. We have no commercial relationships that influence our content. Every research profile is written and reviewed with the same standards regardless of a compound’s popularity or commercial availability.
Read our full Editorial Policy for details on how we source, verify, and present research.
Our Approach to Evidence
We weight evidence by quality. Randomised controlled trials carry more weight than animal studies. We clearly label research stages — preclinical, Phase I, Phase II, Phase III, approved — so readers always know how strong the evidence is for any given claim.
Where evidence is limited or conflicting, we say so. We would rather present an honest “the data is inconclusive” than overstate findings for engagement.
Who We Are
PeptideGuide is maintained by a small editorial team with backgrounds in biochemistry, pharmacology, and health science communication. We are researchers and science writers — not clinicians. Our content is reviewed for accuracy but is not a substitute for professional medical consultation.
Contact
Have a correction, suggestion, or question? We welcome feedback from researchers, clinicians, and readers. Reach us via our contact page or email editor@peptideguide.com.